Coronary heart disease with anxiety and/or depression
Conditions
Interventions
Treatment group :Standard western medicine treatment for CHD as mentioned above combined with QSTMAS Herbal Paste
Control group:Standard western medicine treatment for CHD
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: a)Confirmed to the diagnostic criteria of SCAD; b)Confirmed to TCM syndrome of Qi deficiency and blood stasis; c)Confirmed to the diagnostic criteria of mild and moderate anxiety and/or depression using psychological evaluation scales and the early warning system of China-Japan Friendship Hospital; d)Age 18-65 years old; e)Accept and cooperate with the trial scheme f)Volunteer to participate in this study and sign the informed consent forms. People Who meet the above requirements were included in this study.
Exclusion criteria
Exclusion criteria: a)Patients who are receiving anxiolytics, antidepressants or drugs for other mental disorders within one month; b)Combined with severe cardiac insufficiency, such as Killip grade II and above; NYHA grade III and above; c)Combined with other serious diseases, such as severe liver and kidney dysfunction (ALT > 3 × upper limits of normal, SCR > 221 µ mol/L); Severe consumption state or malignant tumor; d)Pregnant or lactating women, or those with pregnancy plans; e)Suspicious or definite allergy to Traditional Chinese Medicine or proprietary Chinese medicine; f)Those who use with similar efficacy to the Traditional Chinese Medicine within 2 weeks; g)Those who are participating in other clinical studies now or within one month. If any of the above conditions are met, it will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| GAD-7 and PHQ-9 scale scores; | — |
Countries
China
Contacts
Public Contactxiaoxiang
Outcome results
None listed